Aardvark Therapeutics, Inc. is a clinical stage biopharmaceutical company focused on the development and commercialization of small molecule therapeutics that activate innate homeostatic pathways for the treatment of disease. Their goal is to become a leader in the treatment of hunger, which has potential applications in the treatment of hyperphagia in rare diseases as well as obesity and
…More obesity-related conditions.